Metformin, an insulin-lowering agent, has been associated with decreased cancer risk in
epidemiologic studies in diabetic patients. We performed a comprehensive literature search …

Objective. Oral antidiabetic drugs (including metformin and sulfonylurea) may play a role in
the relationship between type 2 diabetes and cancer. To quantify the association between …

OBJECTIVE The antidiabetic properties of metformin are mediated through its ability to
activate the AMP-activated protein kinase (AMPK). Activation of AMPK can suppress tumor …

Background: The potential of an increased risk of breast cancer in women with diabetes has
been the subject of a great deal of recent research. Methods: A meta-analysis was …

Convincing evidence now supports a probable preventive role for physical activity in
postmenopausal breast cancer. The mechanisms by which long-term physical activity affect …

The aim of this meta-analysis was to collate and analyse all primary observational studies
investigating the risk of breast cancer (BC) associated with diabetes. In addition, we aimed …

Nutrition science is a highly fractionated, contentious field with rapidly changing viewpoints
on both minor and major issues impacting on public health. With an evolutionary perspective …

Diabetes is one of the most important chronic conditions worldwide, and breast cancer is the
most prevalent cancer in women worldwide. Several types of research have been conducted …

Aim of the study To clarify the relationship between the presence of metabolic syndrome and
the incidence of cancer in a general Japanese population. Methods A retrospective cohort …

Obesity predisposes to cancer and a virtual universality of nonalcoholic fatty liver disease
(NAFLD). However, the impact of hepatic steatosis on liver metastasis is enigmatic. We find …